Oxytocic drugs

  • M. Bamber
  • M. G. Elder


Oxytocic drugs are those used to stimulate uterine activity. In the past 10–20 years there has been much change in the use of drugs that control uterine activity. Former agents such as ‘buccal pitocin’ and ‘pill ergot’ have been overtaken by newer drugs such as the prostaglandins. The assessment of the efficacy and safety of such newer drugs is dependent on measurable observations which reflect uterine activity. This chapter outlines (a) the clinical applications of oxytocic drugs and (b) the methods of evaluation of such agents in each of the above applications.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Alvarez, H. and Caldeyro-Barcia, R. (1950). Contractility of human uterus recorded by new methods. Surg. Gynaecol. Obstet., 91, 1–13Google Scholar
  2. Amato, J. C. (1977). Fetal monitoring in a community hospital. A statistical analysis. Obstet. Gynecol., 50, 269–74PubMedGoogle Scholar
  3. Anthony, G. S., Fisher, J., Coutts, J. R. T. and Calder, A. A. (1982). Forces required for surgical dilatation of the pregnant and non-pregnant human cervix. Br. J. Obstet. Gynaecol., 89, 913–16CrossRefPubMedGoogle Scholar
  4. Beazley, J. M. and Gillespie, A. (1971). Double-blind trial of prostaglandin E2 and oxytocin in induction of labour. Lancet, 1, 152–5CrossRefPubMedGoogle Scholar
  5. Bell, G. H. (1952). Abnormal uterine action in labour. J. Obst. Gynaecol. Br. Emp., 59, 617–23CrossRefGoogle Scholar
  6. Bidgood, K. A. (1988). Oxytocin augmentation of labour. In Chamberlain, G. (Ed.), Contemporary Obstetrics and Gynaecology. Butterworths, London, pp. 225–42Google Scholar
  7. Bishop, E. H. (1964). Pelvic scoring for elective induction. Obstet. Gynecol., 24, 266–8PubMedGoogle Scholar
  8. Braaksma, J. T., Veth, A. F. L., Janssens, J., Stolte, L. A. M., Eskers, T. K. A. B., Hein, P. R. and Van Der Weide, H. (1971). A comparison of digital and non-digital analysis of contraction records obtained from the non-pregnant uterus in vivo. Am. J. Obstet. Gynecol., 110, 1075–82PubMedGoogle Scholar
  9. Buchan, P. C. (1979). Pathogenesis of neonatal hyperbilirubinaemia after induction of labour with oxytocin. Br. Med. J., ii, 1255–7CrossRefGoogle Scholar
  10. Calder, A. A. (1979). In Kierse, M. J. N. C., Anderson, A. B. M. and Bennebroek Gravenhoist, J. (Eds.), Human Parturition. University Press, Leiden, pp. 201–17CrossRefGoogle Scholar
  11. Calder, A. A., Moar, V. A., Ounsted, M. K. and Turnbull, A. C. (1974). Increased bilirubin levels in neonates after induction of labour by intravenous prostaglandin E2 or oxytocin. Lancet, ii, 1339–42CrossRefGoogle Scholar
  12. Caldeyro-Barcia, R. and Alvarez, H. (1952). Abnormal uterine action in labour. J. Obstet. Gynaecol. Br. Commonw., 59, 646–54Google Scholar
  13. Cameron, I. T. and Baird, D. T. (1984). The use of 16, 16-dimethyl trans delta 2 prostaglandin E1 methyl ester (gemeprost) vaginal pessaries for the termination of pregnancy in the early second trimester. A comparison with extra-amniotic prostaglandin E2. Br. J. Obstet. Gynaecol., 91, 1136–40CrossRefPubMedGoogle Scholar
  14. Cameron, I. T. and Baird, D. T. (1988). Early pregnancy termination: a comparison between vacuum aspiration and medical abortion using prostaglandin (16, 16 dimethyl-trans-D2-PGE, methyl ester) or the antiprogestogen RU 486. Br. J. Obstet. Gynaecol., 95, 271–6CrossRefPubMedGoogle Scholar
  15. Carter, M. C. and Steer, P. J. (1980). A closed-loop oxytocin infusion system: preliminary results of clinical trials. In Rolfe, P. (Ed.), Fetal and Neonatal Physiological Measurements. Pitman Press, Bath, pp. 165–76Google Scholar
  16. Chan, W. H., Paul, R. H. and Toews, J. (1973). Intrapartum fetal monitoring—maternal and fetal morbidity and perinatal mortality. Obstet. Gynecol., 41, 7–13PubMedGoogle Scholar
  17. Coltart, T. M. and Coe, M. J. (1975). Intravenous prostaglandins and oxytocin for mid-trimester abortion. Lancet, 1, 174–5Google Scholar
  18. Couzinet, B., Lestrat, N., Ulmann, A., Baulieu, E. E. and Schaison, G. (1986). Termination of early pregnancy by progesterone antagonist RU 486 (Mifepristone). New Engl. J. Med., 315, 1565–70CrossRefPubMedGoogle Scholar
  19. Csapo, A. I. (1970). The diagnostic significance of intrauterine pressure—I. Obstet. Gynaecol. Surv., 25, 403–35CrossRefGoogle Scholar
  20. Csapo, A. I., Mocsary, P. and Nagy, T. (1973). The efficacy and acceptability of the ‘prostaglandin impact’ in inducing complete abortion during the second week after the missed menstrual period. Prostaglandins, 3, 125–39CrossRefPubMedGoogle Scholar
  21. Daw, E. (1973). Oxytocin-induced rupture of the primigravid uterus. J. Obstet. Gynaecol. Br. Commonw., 80, 374–5CrossRefPubMedGoogle Scholar
  22. Dingfelder, J. R., Brenner, W. E. and Hendricks, C. H. (1975). Reduced cervical resistance by prostaglandin suppositories prior to dilatation for induced abortion. Am. J. Obstet. Gynecol., 122, 25–30PubMedGoogle Scholar
  23. Fernandez-Rocha, L. and Oulette, R. (1976). Fetal bleeding; an unusual complication of fetal monitoring. Am. J. Obstet. Gynecol., 125, 1153–4PubMedGoogle Scholar
  24. Fisher, J., Anthony, G. S., McManus, T. J., Coults, J. R. T. and Calder, A. A. (1981). Use of a force measuring instrument during cervical dilatation. J. Med. Eng. Tech., 5, 194–5CrossRefGoogle Scholar
  25. Friedman, E. A., Niswander, K. R., Bayonet-Rivera, N. P. and Sachtleben, M. R. (1966). Relation of prelabour evaluation in inducibility and the course of labour. Obstet. Gynecol., 28, 495–501PubMedGoogle Scholar
  26. Ghosh, A. and Hudson, F. P. (1972). Oxytocic agents and neonatal hyperbilirubinaemia. Lancet, ii, 823–5CrossRefGoogle Scholar
  27. Hayashi, R. H., Castillo, M. S. and Noah, M. L. (1981). Management of severe postpartum haemorrhage due to uterine atony using an analogue of Prostaglandin F2. Obstet. Gynecol., 58, 426–9PubMedGoogle Scholar
  28. Hellman, L. M., Harris, J. and Reynolds, S. R. M. (1950). Characteristics of the gradients of uterine contractility during the first stage of true labour. Bull. Johns Hopkins Hosp., 86, 234–48PubMedGoogle Scholar
  29. Hendricks, C. H. (1983). Second thoughts on induction of labour. In Studd, J. (Ed.), Progress in Obstetrics and Gynaecology, Vol. 3. Churchill Livingstone, London, pp. 101–12Google Scholar
  30. Hendricks, C. H., Brenner, W. E. and Kraus, G. (1970). Normal cervical dilatation pattern in late pregnancy and labour. Am. J. Obstet. Gynecol., 106, 1065–82PubMedGoogle Scholar
  31. Henson, G., Gough, J. D. and Gillmer, M. D. G. (1983). Control of persistent primary postpartum haemorrhage due to uterine atony with intravenous prostaglandin E2. Br. J. Obstet. Gynaecol., 90, 280–2CrossRefPubMedGoogle Scholar
  32. Hicks, J. B. (1871). On the contractions of the uterus throughout pregnancy: their physiological effects and their value in the diagnosis of pregnancy. Trans. Obstet. Soc., London, 216Google Scholar
  33. Hon, E. H. and Paul, R. H. (1973). Quantitation of uterine activity. Obstet. Gynecol., 42, 368–70PubMedGoogle Scholar
  34. Huey, J. R., Al-Hadjer, A. and Paul, R. W. (1976). Uterine activity in the multiparous patient. Am. J. Obstet. Gynecol., 126, 682–6PubMedGoogle Scholar
  35. Hulka, J. F., Lefler, H. T., Anglone, A. and Lachenbruch, P. A. (1974). A new electronic force monitor to measure factors influencing cervical dilatation for vacuum curettage. Am. J. Obstet. Gynecol., 120 (2), 166PubMedGoogle Scholar
  36. Iqbal, P. K., Hopkins, R. E., Stevenson, T. C., Mayers, F. N. and Gartside, M. W. (1988). Br. J. Obstet. Gynaecol., 95, 827–8CrossRefPubMedGoogle Scholar
  37. Jeffcoate, T. N. A. (1961). Prolonged labour. Lancet, ii, 61–7CrossRefGoogle Scholar
  38. Jilek, J., Hon, E. H. and Yeh, S. Y. (1972). A technique for the measurement of uterine activity. Med. Res. Eng., 11, 4–5PubMedGoogle Scholar
  39. Karim, S. M. M. and Ratnam, S. S. (1976). Termination of pregnancy with prostaglandin analogues. In Sammulsson, B. and Paoletti, R. (Eds.), Advances in Prostaglandin and Thromboxane Research. Raven Press, New York, p. 727Google Scholar
  40. Kovacs, L., Sas, M., Resch, B. A., Ugoscai, G., Swahn, M. L., Bygdeman, M. and Rowe, P. J. (1984). Termination of very early pregnancy by RU 486—an antiprogestational compound. Contraception, 29, 399–410CrossRefPubMedGoogle Scholar
  41. Liggins, G. C. (1962). The treatment of missed abortion by high dosage syntocinon intravenous infusion. J. Obstet. Gynaecol. Br. Commonw., 69, 277–81CrossRefGoogle Scholar
  42. Mackenzie, I. L. and Embrey, M. P. (1977). Cervical ripening with intravaginal prostaglandin E2 gel. Br. Mr. J., 2, 1381–4CrossRefGoogle Scholar
  43. Miller, F. C. (1981). Quantitation of uterine activity. Clin. Perinatol., 8, 27–34PubMedGoogle Scholar
  44. Miller, F. C., Mueller, E. and Vellick, K. (1976). Quantitation of uterine activity in 100 primiparous patients. Am. J. Obstet. Gynecol., 124, 398–405PubMedGoogle Scholar
  45. O’Driscoll, K. and Meagher, D. (1986). In O’Driscoll, K. and Meagher, D. (Eds.), Active Management of Labour. Baillière Tindall, London, pp. 24–31Google Scholar
  46. Philpott, R. H. and Castle, W. M. (1972). Cervicographs in the management of labour in Primigravidae. The alert line for detecting abnormal labour. J. Obstet. Gynaecol. Brit. Commonw., 79, 592–8CrossRefGoogle Scholar
  47. Pontonnier, G., Puech, F., Granjean, H. and Holland, M. (1975). Some physical and biochemical parameters during normal labour. Biol. Neonate, 26, 159CrossRefPubMedGoogle Scholar
  48. Prasad, R. N. V., Lim, C. and Wong, Y. C. (1978). Vaginal administration of 16, 16-dimethyl-trans-D2-PGE, methyl ester (ONO 802) for pre-operative cervical dilatation in first trimester nulliparous pregnancy. Singapore J. Obstet. Gynaecol., 9, 69–71Google Scholar
  49. Reynolds, J. R. M., Heard, O. O., Bruns, P. and Hellman, L. M. (1948). A multichannel straingage tokodynamometer—an instrument for studying patterns of uterine contractions in pregnant women. Bull. Johns Hopkins Hosp., 82, 449–69Google Scholar
  50. Samir, E. S., Gaafar, A. A. and Toppozada, H. K. (1967). A new unit for evaluation of uterine activity. Am. J. Obstet. Gynecol., 98, 900–3Google Scholar
  51. Seitchik, J. and Chatkoff, M. L. (1975). Intrauterine pressure waveform characteristics in hypocontractile labor before and after oxytocin administration. Am. J. Obstet. Gynecol., 123, 426–34PubMedGoogle Scholar
  52. Smyth, C. N. (1957). The guardring tocodynamometer—an absolute measurement of intra-amniotic pressure by a new instrument. J. Obstet. Gynaecol. Br. Commonw., 64, 59–66CrossRefGoogle Scholar
  53. Steer, P. J. (1977). Monitoring of labour. Br. J. Hosp. Med., 17, 219–25PubMedGoogle Scholar
  54. Studd, J. W. W., Cardozo, L. D. and Gibb, D. M. F. (1982). The management of spontaneous labour. In Studd, J. (Ed.), Progress in Obstetrics and Gynaecology, Vol. 2. Churchill Livingstone, London, pp. 60–72Google Scholar
  55. Swahn, M. L. and Bygdeman, M. (1988). The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin oxytocin. Br. J. Obstet. Gynaecol., 95, 126–34CrossRefPubMedGoogle Scholar
  56. Takagi, S., Sakata, H., Yoshida, T., Nakazawa, S., Fujii, K. T., Tominaga, Y., Iwasa, Y., Ninagawa, T., Hiroshima, T., Tomida, Y., Itoh, K. and Matsukawa, R. (1977). Termination of early pregnancy by ONO-802 (16, 16-Dimethyl-trans-D2-PGE, methyl ester). Prostaglandins, 14, 791–8CrossRefPubMedGoogle Scholar
  57. Thiery, M. (1986). Prostaglandins for the treatment of hypotonic postpartum haemorrhage. Prostaglandins Perspectives, 2 (3), 11–12Google Scholar
  58. Tutera, G. and Newman, R. L. (1975). Fetal monitoring; its effect on the perinatal mortality and caesarean section rates and its complications. Am. J. Obstet. Gynecol., 122, 750–4PubMedGoogle Scholar
  59. Ulmsden, U., Wingerup, L., Beitrage, P., Ekman, G. and Wiqvist, N. (1982). Intracervical application of prostaglandin gel for induction of term labour. Obstet. Gynecol., 56, 336–9Google Scholar
  60. Welch, C. and Elder, M. G. (1982). Cervical dilatation with 16, 16-dimethyl-trans-D2-PGE, methyl ester vaginal pessaries before surgical termination of first trimester pregnancies. Br. J. Obstet. Gynaecol., 89, 849–52CrossRefPubMedGoogle Scholar
  61. Wiqvist, N., Bygdeman, M. and Toppozada, M. (1971). Induction of abortion by the intravenous administration of prostaglandin F2. A critical evaluation. Acta Obstet. Gynecol. Scand., 50, 381–9CrossRefPubMedGoogle Scholar
  62. Wood, C., Bannerman, R. H. O., Booth, R. T. and Ankerton, J. H. M. (1965). The prediction of premature labour by observation of the cervix and external tocography. Am. J. Obstet. Gynecol., 91, 396–402PubMedGoogle Scholar
  63. Wright, C., Campbell, S. and Beazley, J. (1972). Second trimester abortion after vaginal termination of pregnancy. Lancet, 1, 1278–9CrossRefPubMedGoogle Scholar

Copyright information

© The editors and contributors 1990

Authors and Affiliations

  • M. Bamber
    • 1
  • M. G. Elder
    • 2
  1. 1.Rhône-Poulenc LtdDagenhamUK
  2. 2.RPMS Institute of Obstetrics and GynaecologyHammersmith HospitalLondonUK

Personalised recommendations